HSG Collaboration – Publications

As a Huntington Study Group site, investigators and participants from our Center have contributed to the following studes.

Clinical Trials - ARTICLES

1. Huntington Study Group (Marshall F, primary author).  Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington’s disease.  Neurol 1998;50:1366-1373.
2. The Huntington Study Group (Kieburtz K, primary author).  A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease.  Neurol 2001;57:397-404.
3. Huntington Study Group (Marshall F, primary author).  Dosage effects of riluzole in Huntington’s disease: a multicenter placebo-controlled study.  Neurol 2003; 61:1551-1556.
4. Huntington Study Group (Cudkowicz M, primary author).  Minocycline safety and tolerability in Huntington's disease.  Neurol 2004;63:547-549.
5. Huntington Study Group, (Marshall F, primary author). Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology 2006;66:366-372.
6. Marshall FJ, Fahn S, Clarence-Smith K (Reply from the authors). Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology 2007;68:797.
7. Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington’s disease.  Clinical Neuropharmacology (in press).